XNYS
BFLY
Market cap1.53bUSD
Jun 17, Last price
5.71USD
1D
1.06%
1Q
43.83%
IPO
-42.44%
Name
Butterfly Network Inc
Chart & Performance
P/E
—
P/S
18.21
EPS
—
Div Yield, %
—
Shrs. gr., 5y
103.56%
Rev. gr., 5y
24.36%
Revenues
82m
+24.52%
Net income
-72m
L-45.78%
CFO
-42m
L-57.79%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Butterfly Network, Inc. focuses on developing cost-effective, real-time, and three-dimensional medical imaging technology for both diagnosis and treatment. Its core offering is the iQ Device, a portable, whole-body ultrasound scanner, which is integrated with a comprehensive ecosystem of digital services. These services include a cloud-based application, application programming interfaces (APIs), and platform functionalities. These advanced tools are provided to physicians and other licensed healthcare providers. The company's diverse product portfolio includes iQ+ Ultrasound, Butterfly Enterprise, and iQ Vet. Jonathan M. Rothberg founded the company on January 25, 2011, and it is headquartered in Burlington, MA.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||